ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Arena Pharma Raising $352 Million Following Positive Phase II Data
March 23, 2018Earlier this week, Arena Pharmaceuticals, Inc.’ shares rose 34 percent in premarket trading after the company released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis (UC). -
Everest to offer two Arena Pharma drugs in Asian countries
December 08, 2017US-based Arena Pharmaceuticals formed a development and commercialisation alliance with Chinese C-Bridge Capital-backed Everest Medicines for offering ralinepag and etrasimod in selected Asian countries.
Pharma Sources Insight January 2025
